Researchers explore the impact of virtual collaborative care on mental health and quality of life for breast cancer patients, revealing significant improvements.
Nina Balanchivadze, MD, FACP
Advertisement
Nina Balanchivadze, MD, FACP, is a hematologist/oncologist at Sarah Cannon Research Institute at Virginia Oncology Associates.
Articles by Nina Balanchivadze, MD, FACP
Experts explore a virtual collaborative care model to enhance mental health support for breast cancer patients, aiming to improve treatment adherence and outcomes.
Nina Balanchivadze, MD, FACP, discusses how inclusive research begins at the community level by addressing barriers to trial participation.
Nino Balanchivadze, MD, FACP, discusses the rationale for evaluating toxicity based on race in the KEYNOTE-189 study.
Nino Balanchivadze, MD, FACP, discusses the results of an analysis investigating renal toxicity in patients with nonsquamous non–small cell lung cancer in relation to the race of patients.
Advertisement
Latest Updated Articles
Breaking Trial Barriers Through Community-Inclusive ResearchPublished: July 29th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Breakthrough Status to Sevabertinib in 1L HER2+ NSCLC
2
FDA and EMA Grant Orphan Drug Status to Novel Imaging Drug for Pancreatic Cancer
3
Ongoing Trials Could Expand Role of IDH Inhibitors in Resected Glioma
4
Phase 3 Trial of Calderasib Combo Launched in Advanced KRAS G12C-Mutant NSCLC
5